People

Ranking and references

Cirio Advokatbyrå AB is particularly active in the life sciences and digital spaces, and is very experienced in advising on patent litigation and licensing issues. Practice head Hanna Tilus brings expertise in marketing law, and has a solid track record in acting for clients in the pharmaceutical sector. (Intellectual Property and Media) – Legal 500

Praised for her specialism in personal data protection which makes her ‘unique within the Swedish market‘, Hanna Tilus is known for advising on technology transfers, co-marketing issues, and R&D collaborations. (Healtcare and Life Sciences) – Legal 500

Practice head Hanna Tilus has expertise in tech-related regulatory matters, commercial agreements, and IP issues. (IT and Telecoms) – Legal 500

‘Hanna Tilus has exceptional skills in building the case for the court, very thorough, deep understanding of both scientific and commercial aspects and outstanding communication with the client in a clear and effective way.’ – Legal 500

Hanna Tilus shows great experience in a vast number of areas and questions specifically connected to the life sciences segment, which is unusual and hard to find in other law firms in general. She gave valuable advice on both regulatory questions and transactional law matters.’- Legal 500

Per Hedman and Hannah Tilus are incredibly approachable, responsive and very talented lawyers. They are able to deliver solution focused advice on highly complex regulatory issues. They are a pleasure to work with and are our go to for all life sciences and healthcare queries for Sweden. They are highly recommended.’- Legal 500

Per Hedman and his team have significant expertise in life sciences and healthcare law. They are approachable, practical, extremely knowledgeable and give superb practical advice. They are our go to firm for all Swedish life sciences and healthcare work and we have worked together on many matters. The team always delivers work to an exceptional standard even under extremely tight deadlines. Hannah Tilus deserves a special mention – she is fantastic.’ – Legal 500

Hanna Tilus

Partner

Hanna Tilus is a partner and head of Cirio's Digitalization and Technology sector group. She is specialising in intellectual property, marketing law, consumer law, personal data protection, regulatory and commercial contracts. In addition, she has a strong focus on the Life Sciences sector.

Hanna has significant experience from advising a wide range of companies within the life sciences sector including pharmaceuticals, medtech, healthcare and food companies. Furthermore, Hanna has in-house experience of the life sciences sector from working at Bayer, a global life sciences company, where she was responsible for legal affairs, corporate compliance and data protection primarily in Sweden but also in relation to global issues from her time at the Berlin HQ.

Hanna also has substantial experience from advising clients in various sectors with respect to IP- and technology-related matters including M&A, licensing, technology transfers, co-marketing, R&D collaborations, complex commercial contracts, multi-jurisdictional IP-litigation and administrative appeals.

CV

2021 Cirio Law Firm
2019 - 2021 Roschier Attorneys, Counsel IP & Life Sciences
2014 - 2018 Bayer AB, Senior Legal Counsel, Compliance Manager and Company Data Privacy Manager
2010 - 2011 H&M Hennes & Mauritz AB, Visiting lawyer
2008 - 2014 Advokatfirman Lindahl, Senior Associate

Education

2008 Stockholm University, LL.M.
2005 Stockholm University, Bachelor's degree Psychology
2005 Queensland University of Technology, University Study Abroad Certificate, Business

Membership

2019 Member of the Swedish Bar Association

Languages

Swedish
English

Publications

"Pricing & Reimbursement 2023”, Global Legal Insights
“Licensing 2023”, Getting the Deal Through
“Life Sciences 2023”, Getting the Deal Through
Intermistiskt förbud i patentmål” (Preliminary injunction in patent cases) co-authored with Hampus Rystedt, PatentEye 3/2019
“Vad händer med de immateriella tillgångarna i en konkurs?” (“What happens to the Intellectual Property Assets in a bankruptcy?”) , co-authored with Johan Hörnberg, Brand News 5/2013
“Den specifika mekanismen – ett undantag från den tillåtna parallellimporten av läkemedel” (The Specific Mechanism – an exception from the approved parallell import of Pharmaceuticals), co-authored with Håkan Borgenhäll, Patent Eye 2/2013
Chapter “When you are copied – IP litigation and alternative dispute resolution” in The Handbook of European Intellectual Property Management 3rd edition KoganPage /Adam Jolly 2012, co-authored with Håkan Borgenhäll
“The Pirate Bay case and implications of AIPPI membership for judges”, co-authored with Jonas Westerberg, AIPPI e-News 21 November 2011
“Barnförordningen ger möjlighet till förlängt tilläggsskydd” (“The Paediatric Regulation gives an opportunity to an extended Supplementary Protection Certificate”), co-authored with Håkan Borgenhäll, Patent Eye 2/2009
Patenteye 2009 “Swedish courts makes pirates pay”, co-authored with Henrik Wistam, Copyright World Magazine issue #191, June 2009

Ranking and references

Cirio Advokatbyrå AB is particularly active in the life sciences and digital spaces, and is very experienced in advising on patent litigation and licensing issues. Practice head Hanna Tilus brings expertise in marketing law, and has a solid track record in acting for clients in the pharmaceutical sector. (Intellectual Property and Media) – Legal 500

Praised for her specialism in personal data protection which makes her ‘unique within the Swedish market‘, Hanna Tilus is known for advising on technology transfers, co-marketing issues, and R&D collaborations. (Healtcare and Life Sciences) – Legal 500

Practice head Hanna Tilus has expertise in tech-related regulatory matters, commercial agreements, and IP issues. (IT and Telecoms) – Legal 500

‘Hanna Tilus has exceptional skills in building the case for the court, very thorough, deep understanding of both scientific and commercial aspects and outstanding communication with the client in a clear and effective way.’ – Legal 500

Hanna Tilus shows great experience in a vast number of areas and questions specifically connected to the life sciences segment, which is unusual and hard to find in other law firms in general. She gave valuable advice on both regulatory questions and transactional law matters.’- Legal 500

Per Hedman and Hannah Tilus are incredibly approachable, responsive and very talented lawyers. They are able to deliver solution focused advice on highly complex regulatory issues. They are a pleasure to work with and are our go to for all life sciences and healthcare queries for Sweden. They are highly recommended.’- Legal 500

Per Hedman and his team have significant expertise in life sciences and healthcare law. They are approachable, practical, extremely knowledgeable and give superb practical advice. They are our go to firm for all Swedish life sciences and healthcare work and we have worked together on many matters. The team always delivers work to an exceptional standard even under extremely tight deadlines. Hannah Tilus deserves a special mention – she is fantastic.’ – Legal 500

CV

2021 Cirio Law Firm
2019 - 2021 Roschier Attorneys, Counsel IP & Life Sciences
2014 - 2018 Bayer AB, Senior Legal Counsel, Compliance Manager and Company Data Privacy Manager
2010 - 2011 H&M Hennes & Mauritz AB, Visiting lawyer
2008 - 2014 Advokatfirman Lindahl, Senior Associate

Education

2008 Stockholm University, LL.M.
2005 Stockholm University, Bachelor's degree Psychology
2005 Queensland University of Technology, University Study Abroad Certificate, Business

Membership

2019 Member of the Swedish Bar Association

Languages

Swedish
English

Publications

"Pricing & Reimbursement 2023”, Global Legal Insights
“Licensing 2023”, Getting the Deal Through
“Life Sciences 2023”, Getting the Deal Through
Intermistiskt förbud i patentmål” (Preliminary injunction in patent cases) co-authored with Hampus Rystedt, PatentEye 3/2019
“Vad händer med de immateriella tillgångarna i en konkurs?” (“What happens to the Intellectual Property Assets in a bankruptcy?”) , co-authored with Johan Hörnberg, Brand News 5/2013
“Den specifika mekanismen – ett undantag från den tillåtna parallellimporten av läkemedel” (The Specific Mechanism – an exception from the approved parallell import of Pharmaceuticals), co-authored with Håkan Borgenhäll, Patent Eye 2/2013
Chapter “When you are copied – IP litigation and alternative dispute resolution” in The Handbook of European Intellectual Property Management 3rd edition KoganPage /Adam Jolly 2012, co-authored with Håkan Borgenhäll
“The Pirate Bay case and implications of AIPPI membership for judges”, co-authored with Jonas Westerberg, AIPPI e-News 21 November 2011
“Barnförordningen ger möjlighet till förlängt tilläggsskydd” (“The Paediatric Regulation gives an opportunity to an extended Supplementary Protection Certificate”), co-authored with Håkan Borgenhäll, Patent Eye 2/2009
Patenteye 2009 “Swedish courts makes pirates pay”, co-authored with Henrik Wistam, Copyright World Magazine issue #191, June 2009

Related news

Decision on the AI Act on the 21 May

Decision on the AI Act Background The rapid development of artificial intelligence (‘AI’) in the recent years has certainly not…

  • Data Privacy and Information Security
  • Digitalization and Technology 

The latest digital developments in the EU

On 10 April 2024, Cirio’s Digital Technology team held a seminar on the latest digital developments in the EU, a…

  • Digitalization and Technology 

Cirio advises ABB in its minority investment in Salt X

Cirio has advised ABB in its minority investment in Salt X, a Sweden-based greentech company.   Cirio’s team consisted of…

  • Equity Capital Markets and Public M&A
  • Intellectual Property
  • Digitalization and Technology 

New regulation on fair access to and use of data (Data Act)

The Data Act has recently entered into force. The regulation aims to make it easier for different actors to access…

  • Data Privacy and Information Security
  • Digitalization and Technology 

Cirio legal advisor to Stockholm Live in connection with a new naming rights agreement for the National Arena

Cirio has advised Stockholm Live in connection with entering into a new naming rights agreement for the National Arena in…

  • Intellectual Property

Article – A compromise agreement on the AI Act has been reached

A compromise agreement on the AI Act has been reached Artificial intelligence (AI) is and has been a hot topic…

IBA Annual Conference in Paris 2023

IBA Annual Conference in Paris 2023 Originally founded in 1918, the firm adopted the name Cirio a hundred years later…

Cirio Digital Forum 2023

Välkommen till Cirio Digital Forum – Kunddata och beteendedata som outnyttjad eller väl utnyttjad resurs För tredje året i rad…

  • Digitalization and Technology 

Cirio has advised Lauxera Capital Partners on a strategical investment in BioLamina

Cirio acted as legal advisor to Lauxera Capital Partners on €17 million investment in the Swedish cell culture company BioLamina…

  • Mergers & Acquisitions
  • Life Sciences
  • Employment Law
  • Life Science, Healthcare & Food

Cirio contributes to Global Legal Insights – Pricing & Reimbursement 2023

Cirio is happy to share our contribution to Global Legal Insights – Pricing & Reimbursement Sixth Edition. This chapter provides…

  • Life Science, Healthcare & Food

EUs New Deal For Consumers

Visste du att det inte längre är tillåtet att sälja en vara i befintligt skick och att fristen för den…

Cirio advises SignUp Software on SEK 2.4 billion public takeover offer by Insight Partners

Insight Partners have, through SUS Intermediate Company AB, launched a recommended cash offer to the shareholders of SignUp Software AB…

  • Equity Capital Markets and Public M&A
  • Digitalization and Technology 

Cirio advises Zoo.se in connection with its acquisition of Tinybuddy

Cirio has assisted Swedish pet service and product company ZOO.se Trading i Norden AB in its acquisition of the e-commerce…

  • Mergers & Acquisitions
  • Intellectual Property
  • Employment Law
  • Digitalization and Technology 

Cirio advises Besqab with its 825 million fully secured preferential rights issue

Cirio acts as legal adviser to Besqab AB (publ) in connection with its fully secured preferential rights issue of approximately…

  • Real Estate

Cirio advises Ipsen on Acquisition of Liver Disease Treatment Innovator Albireo

Cirio has advised Ipsen on its acquisition of Albireo Pharma Inc. Ipsen and Albireo have, on 9 January 2023, entered…

  • Mergers & Acquisitions
  • Life Sciences

Cirio advises Boule in connection with its fully secured preferential rights issue

Cirio acts as legal adviser to Boule Diagnostics AB (publ) in connection with its fully secured preferential rights issue of…

  • Equity Capital Markets and Public M&A
  • Life Sciences
  • Banking and Finance and DCM (Debt Capital Markets)
  • Intellectual Property
  • Life Science, Healthcare & Food

Cirio Life Science Forum del 4 – Digital hälsa

Det nyss överståndna valet har medfört flera maktskiften runt om i landet, vid en tidpunkt när digitaliseringen av vården är…

  • Life Sciences

Cirio advises Abliva on its SEK 200 million financing to fund phase 2/3 study

Cirio acted as legal adviser to Abliva AB (publ) in connection with its directed issue of approximately SEK 150 million…

  • Equity Capital Markets and Public M&A

Cirio Life Science Forum del 3 – Om vården inför valet 2022

Erfarenheterna från den gångna pandemin och debatten om privata sjukförsäkringarna har bland annat bidragit till att vården åter är en…

  • Life Sciences

Cirio Life Science Forum del 2 – HTA och cybersäkerhet för MedTech

Kraven på hälsoekonomisk utvärdering (HTA) av medicintekniska produkter växer i takt med att nya regler tar form i Sverige, EU…

  • Life Sciences

Den nya given inom konsumenträtten: Är din verksamhet rustad för det nya regelverket?

EU har under de senaste åren fokuserat på att stärka skyddet för konsumenter genom sin konsumentpolitiska strategi, den s.k. New…

Läkemedelsåret 2021 med utblick mot 2022

Cirio Life Science Forum: Läkemedelsåret 2021 med utblick mot 2022 Välkommen till första delen i webbinarieserien Cirio Life Science Forum….

Cirio advises anch.AI (former AI Sustainability Center) on its seed investment

Cirio acted as legal advisor to anch.AI on its seed investment round, which will allow anch.AI to further develop and…

  • Mergers & Acquisitions
  • Private Equity
  • Digitalization and Technology 

1177-besluten och outsourcing inom hälso- och sjukvården

Vad handlar de omtalade 1177-besluten om där IMY bl.a. utdömt en sanktionsavgift mot företaget MedHelp som outsourcat viss del av…

Cirio contributes to 2022’s edition of Lexology Getting The Deal Through – Life Sciences

Cirio’s Life Sciences team has contributed to year 2022’s edition of Lexology Getting The Deal Through – Life Sciences. To…

  • Life Sciences
  • Life Science, Healthcare & Food

Cirio advises ICA Gruppen in connection with public takeover offer

Cirio has advised ICA Gruppen in connection with public takeover offer. ICA-handlarnas Förbund and AMF Pensionsförsäkring AB have, through Murgröna…

  • Equity Capital Markets and Public M&A
  • Mergers & Acquisitions
  • Life Sciences
  • Competition Law and State Aid